Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
about
Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factorTargeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients.In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia.Cell Trafficking in Chronic Lymphocytic LeukemiaChemokine polymorphisms and lymphoma: a pooled analysisDecreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathwayRole of eotaxin-1 signaling in ovarian cancerChemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.The targets of curcumin.Targeting the bone marrow in Waldenstrom macroglobulinemia.Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?The SDF-1 G > A polymorphism at position 801 plays no role in multiple myeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemia.CCR7 and CXCR4 Expression in Primary Head and Neck Squamous Cell Carcinomas and Nodal Metastases – a Clinical and Immunohistochemical StudyRevisiting the role of interleukin-8 in chronic lymphocytic leukemia.The role of G protein-coupled receptors in lymphoid malignancies.BRD4 profiling identifies critical Chronic Lymphocytic Leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor.Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patienNK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.Relevance of P-glycoprotein on CXCR4+ B cells to organ manifestation in highly active rheumatoid arthritis.CCR4 expression in a case of cutaneous Richter’s transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations
P2860
Q33385676-3A028093-9635-4BB7-91DF-B7A388E3559BQ33654957-10C9A712-CF47-4DF6-A67F-9543770FFFE8Q33708995-7E247A8A-0B04-48EA-92C1-56B8FB07F27DQ33931890-231941C2-15EC-44EA-80FF-FDFE53DAE562Q34037828-CBABF03D-732B-4D08-BB85-B4F513279850Q34078726-4BC62D34-E03B-42ED-BFB2-22191D802785Q35750964-4A4F7094-7C63-4263-9F94-240AF2B2911AQ35769497-3EF5527D-6BF0-4820-B45A-78F121788EE9Q36115034-C5EE0B2C-B255-444E-9E33-17D8C38015E9Q36237839-823F045D-856B-46E9-8D42-D8F98F7BE981Q36352532-F7D45E3D-8D04-4566-A61D-02A44387AAFEQ36384877-5BD727D0-74B5-42E6-90E4-8E5B6A305F4FQ36771955-3660A179-3B33-4C60-869F-1B5126CA182BQ37160334-33B2758B-8478-4FAC-B031-B0D40A7DC1C5Q37351199-FADF3FB0-DA64-4BA1-A873-04EF9026B0CDQ37800949-775DDEAA-56C0-4CB6-B18D-F5789D5AAEA2Q37950586-CB5A9966-1CCD-4E23-B6C4-B632FFAC0679Q37983913-2028AC4D-656E-40FB-B4CB-45A96699274DQ40241226-818B5CA9-54F5-43A2-8562-4E41CB4C7584Q40982180-2E0FDF2D-B64D-478B-B535-A049D1519281Q47136495-AED44AFB-CD14-4F3A-8E8C-7909FFDA8A6BQ47960121-1CB38362-4CA8-44D7-A18E-427B9AA9601DQ49546562-B6C6E970-478A-4228-B4D0-4856F89C7508Q49959959-6CE41FCB-7089-433A-B0FB-26755182B775Q50502690-25B89FB2-05E4-4984-88A2-F192AE3DBDF4Q53733301-8F9F384E-6C81-488D-B8CB-C8F0F0A8931CQ58484348-01013F42-D82E-4943-AE6F-6AE9D083F581
P2860
Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Expression of the chemokine re ...... a/ small lymphocytic lymphoma.
@en
Expression of the chemokine re ...... a/ small lymphocytic lymphoma.
@nl
type
label
Expression of the chemokine re ...... a/ small lymphocytic lymphoma.
@en
Expression of the chemokine re ...... a/ small lymphocytic lymphoma.
@nl
prefLabel
Expression of the chemokine re ...... a/ small lymphocytic lymphoma.
@en
Expression of the chemokine re ...... a/ small lymphocytic lymphoma.
@nl
P2093
P356
P1476
Expression of the chemokine re ...... a/ small lymphocytic lymphoma.
@en
P2093
Anne Novak
Irene M Ghobrial
Karen E Hedin
Mary J Stenson
Nancy D Bone
Neil E Kay
Stephen M Ansell
P304
P356
10.4065/79.3.318
P407
P577
2004-03-01T00:00:00Z